Integrated Filing — IndAS



General information about company

Scrip Code 500120
NSE Symbol DIAMINESQ
MSEI Symbol NOTLISTED
ISIN INE591D01014
Name of company DIAMINES & CHEMICALS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 18-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 08-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 18-05-2026   13:37:00
End date and time of board meeting 18-05-2026   15:20:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 12-02-2026
Indicate Company website link for updated RPT policy of the Company chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://dacl.co.in/wp-content/uploads/2026/04/RPT-Policy-final_12-Feb-2026_final.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 2
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 928.72 3,845.77
Other income 107.81 462.38
Total income 1,036.53 4,308.15
2 Expenses
(a) Cost of materials consumed 881.20 2,581.23
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (196.64) (396.58)
(d) Employee benefit expense 229.95 1,034.96
(e) Finance costs 9.72 30.91
(f) Depreciation, depletion and amortisation expense 87.69 345.51
(f) Other Expenses
1 Other Expenses 318.29 1,964.47
Total other expenses 318.29 1,964.47
Total expenses 1,330.21 5,560.50
3 Total profit before exceptional items and tax (293.68) (1,252.35)
4 Exceptional items 0.00 0.00
5 Total profit before tax (293.68) (1,252.35)
6 Tax expense
7 Current tax (26.28) (26.28)
8 Deferred tax (58.00) (114.70)
9 Total tax expenses (84.28) (140.98)
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations (209.40) (1,111.37)
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period (209.40) (1,111.37)
17 Other comprehensive income net of taxes (162.89) (127.07)
18 Total Comprehensive Income for the period (372.29) (1,238.44)
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,005.34 1,005.34
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 15,353.33
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations -2.14 -11.35
Diluted earnings (loss) per share from continuing operations -2.14 -11.35
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations -2.14 -11.35
Diluted earnings (loss) per share from continuing and discontinued operations -2.14 -11.35
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 5,075.25
Capital work-in-progress 1,941.36
Investment property
Goodwill 0.00
Other intangible assets 2.77
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method 2,452.40
Non-current financial assets
Non-current investments 0.00
Trade receivables, non-current
Loans, non-current 350.75
Other non-current financial assets
1 Other non-current financial assets 6.02
Total of other non-current financial assets 6.02
Total non-current financial assets 356.77
Deferred tax assets (net)
Other non-current assets
1 Other non-current assets 338.12
Total of other non-current assets 338.12
Total non-current assets 10,166.67
2 Current assets
Inventories 2,829.22
Current financial asset
Current investments 0.00
Trade receivables, current 546.71
Cash and cash equivalents 15.73
Bank balance other than cash and cash equivalents 3,257.63
Loans, current 673.94
Other current financial assets
Total of other current financial assets
Total current financial assets 4,494.01
Current tax assets (net) 133.61
Other current assets
1 Other current assets 424.32
Total of other current assets 424.32
Total current assets 7,881.16
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 18,047.83
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,005.34
Other equity 15,353.33
Total equity attributable to owners of parent 16,358.67
Non controlling interest
Total equity 16,358.67
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
Total of other non-current financial liabilities
Total non-current financial liabilities 0.00
Provisions, non-current 35.00
Deferred tax liabilities (net) 241.15
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 276.15
Current liabilities
Current financial liabilities
Borrowings, current 818.57
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 28.60
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 235.93
Total Trade payable 264.53
Other current financial liabilities
1 Other current financial liabilities 263.06
Total of other current financial liabilities 263.06
Total current financial liabilities 1,346.16
Other current liabilities 48.45
1 Other current liabilities 48.45
Total of other current liabilities 48.45
Provisions, current 18.40
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities 1,413.01
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 1,689.16
Total equity and liabilites 18,047.83
Disclosure of notes on assets and liabilities Textual Information(1)



Text Block

Textual Information(1) 1. The above Standalone financial results have been reviewed and recommended by the Audit Committee and taken on record in its meeting held on 18th May, 2026 and subsequently approved by the Board of Directors of the Company in its meeting held on 18th May, 2026. These Standalone financial results have been audited by Statutory Auditors as required under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. 2.The Company has two reportable segments i.e. Speciality Chemicals and Trading in Fruits and Vegetables. 3.The above audited standalone financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) notified under section 133 of Companies Act, 2013, read together with the companies (Indian Accounting Standard) Rules, 2015 (as amended). 4. Figures of corresponding previous year/period(s) have been regrouped /rearranged wherever necessary, to make them comparable. 5. The Government of India has notified the implementation of four new Labour Codes, effective from November 21, 2025, by consolidating and rationalizing 29 existing labour laws. The Company has made provision of Rs. 4.62 Lakhs due to impact of new Labour Codes. Once State Rules are notified by the Government on all aspects of the Codes, the Company will evaluate the impact, if any and would provide appropriate accounting effect basis, such development, as needed.



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Speciality Chemicals 0.0092872 3,845.77
2 Trading in Fruits and Vegetables 0.00 0.00
Total Segment Revenue 928.72 3,845.77
Less: Inter segment revenue 0.00 0.00
Revenue from operations 928.72 3,845.77
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Speciality Chemicals (283.96) (863.38)
2 Trading in Fruits and Vegetables 0.00 (358.06)
Total Profit before tax (283.96) (1,221.44)
i. Finance cost 9.72 30.91
ii. Other Unallocable Expenditure net off Unallocable income 0.00 0.00
Profit before tax (293.68) (1,252.35)
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Speciality Chemicals 18,047.83 18,047.83
2 Trading in Fruits and Vegetables 0.00 0.00
Total Segment Asset 18,047.83 18,047.83
Un-allocable Assets 0.00 0.00
Net Segment Asset 18,047.83 18,047.83
4 Segment Liabilities
Segment Liabilities
1 Speciality Chemicals 1,689.16 1,689.16
2 Trading in Fruits and Vegetables 0.00 0.00
Total Segment Liabilities 1,689.16 1,689.16
Un-allocable Liabilities 0.00 0.00
Net Segment Liabilities 1,689.16 1,689.16
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Gain/(Loss) on measuring equity instruments at Fair Value carried through Other Comprehensive Income (FVTOCI) (261.26) (216.51)
2 Remeasurement gain/(loss) on the Defined Benefit Plans 8.76 5.38
Total Amount of items that will not be reclassified to profit and loss (252.50) (211.13)
2 Income tax relating to items that will not be reclassified to profit or loss (89.61) (84.06)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income (162.89) (127.07)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax (1,252.35)
Adjustments for reconcile profit (loss)
Adjustments for finance costs 30.91
Adjustments for decrease (increase) in inventories 332.78
Adjustments for decrease (increase) in trade receivables, current 261.82
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 43.43
Adjustments for other financial assets, current (409.31)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (612.07)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 345.51
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss (84.43)
Adjustments for provisions, current 568.95
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 43.61
Adjustments for other financial liabilities, non-current (31.82)
Adjustments for unrealised foreign exchange losses gains 3.39
Adjustments for dividend income 15.49
Adjustments for interest income 341.02
Adjustments for share-based payments 11.79
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 13.64
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 161.69
Net cash flows from (used in) operations (1,090.66)
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 85.87
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities (1,176.53)
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 723.69
Other cash payments to acquire equity or debt instruments of other entities 376.71
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 11.29
Purchase of property, plant and equipment 2,135.13
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 15.49
Interest received 385.69
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (1,422.29)
Net cash flows from (used in) investing activities (2,797.97)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 1,115.31
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 816.06
Repayments of borrowings 0.00
Payments of lease liabilities 0.00
Dividends paid 97.84
Interest paid 30.91
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 1,802.62
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (2,171.88)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (2,171.88)
Cash and cash equivalents cash flow statement at beginning of period 2,187.61
Cash and cash equivalents cash flow statement at end of period 15.73





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 K C MEHTA & CO LLP Yes 31-03-2027


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising Preferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 01-10-2024
Amount Raised 1,250.81
Report filed for Quarter ended 31-03-2026
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NA
Comments of the Audit Committee after review None
Comments of the auditors, if any None
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 capital expenditures, working capital requirements, acquisition, investment in technology and for general corporate purpose NA 1,250.81 0.00 1,250.81 0.00 Rs. 12.51 crores (i.e. 25% of the issue i.e. 9,06,390 convertible warrants @ Rs. 138 per warrant) Rs. 11.15 crores (i.e. 75% of issue i.e. Rs. 414 per share) received and 2,69,402 equity shares allotted on 24.03.2026) Note: The Company had received In-Principle approval on September 19, 2024 for issue not exceeding 916390 number of convertible warrants at Rs. 552 per warrant. The Board, in its meeting held on October 01, 2024, had allotted 906390 convertible warrants on receipt of subscription money Rs. 12.51 crores i.e. 25% of the total Issue, on preferential basis to the investors. Further, out of total issued 906390 warrants, the Company had made allotment of 2,69,402 equity shares (conversion of warrants issued on preferential basis), on receipt of exercise money Rs. 11.15 crores (75% of the issue) by passing board resolution at duly convened board meeting on March 24, 2026, to the applicant from whom entire money has been received and rest all warrants were lapsed as at March 31, 2026 (Last date of conversion of warrants into Equity Shares).


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (2)

Amount in (Lakhs)

Mode of Fund Raising Preferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 24-03-2026
Amount Raised 3,752.45
Report filed for Quarter ended 31-03-2026
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NA
Comments of the Audit Committee after review None
Comments of the auditors, if any None
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 capital expenditures, working capital requirements, acquisition, investment in technology and for general corporate purpose NA 1,115.32 0.00 0.00 0.00 Rs. 12.51 crores (i.e. 25% of the issue i.e. 9,06,390 convertible warrants @ Rs. 138 per warrant) Rs. 11.15 crores (i.e. 75% of issue i.e. Rs. 414 per share) received and 2,69,402 equity shares allotted on 24.03.2026) Note: The Company had received In-Principle approval on September 19, 2024 for issue not exceeding 916390 number of convertible warrants at Rs. 552 per warrant. The Board, in its meeting held on October 01, 2024, had allotted 906390 convertible warrants on receipt of subscription money Rs. 12.51 crores i.e. 25% of the total Issue, on preferential basis to the investors. Further, out of total issued 906390 warrants, the Company had made allotment of 2,69,402 equity shares (conversion of warrants issued on preferential basis), on receipt of exercise money Rs. 11.15 crores (75% of the issue) by passing board resolution at duly convened board meeting on March 24, 2026, to the applicant from whom entire money has been received and rest all warrants were lapsed as at March 31, 2026 (Last date of conversion of warrants into Equity Shares).


Signatory Details

Name of signatory Hemaxi Pawar
Designation of person Company Secretary
Place Vadodara
Date 18-05-2026




Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 DIAMINES AND CHEMICALS LIMITED Mr. Amit M Mehta Executive Chairman Remuneration As per the Companies Act, 2013 and Shareholders' Approval 12.00 2.00 2.00 Textual Information(1)
2 DIAMINES AND CHEMICALS LIMITED Mr. Tanmay Godiawala Director Remuneration As per the Companies Act, 2013 and Shareholders' Approval 18.38 3.06 3.06 Textual Information(2)
3 DIAMINES AND CHEMICALS LIMITED Mr. Rajendra Chhabra Professional Director Any other transaction Sitting Fees & Professional Fees 12.00 As per the Companies Act, 2013 and Shareholders' Approval 7.72 0.00 0.90 Textual Information(3)
4 DIAMINES AND CHEMICALS LIMITED Mr. Priyam Jhaveri Independent Director Any other transaction Sitting Fees As per the Companies Act, 2013 and Shareholders' Approval 1.02 0.00 0.00
5 DIAMINES AND CHEMICALS LIMITED Mr. Dhruv Mehta Independent Director Any other transaction Sitting Fees As per the Companies Act, 2013 and Shareholders' Approval 1.10 0.00 0.00
6 DIAMINES AND CHEMICALS LIMITED Mrs. Kejal Pandya Independent Director Any other transaction Sitting Fees As per the Companies Act, 2013 and Shareholders' Approval 1.72 0.00 0.00
7 DIAMINES AND CHEMICALS LIMITED Finorga (India) Private Limited Promoters Group Any other transaction Rent of Mumbai Office 7.66 As per agreement in compliance with the Companies Act, 2013 3.83 0.58 0.58 Textual Information(4)
8 DIAMINES AND CHEMICALS LIMITED DACL Fine Chem Limited Wholly Owned Subsidiary company Loan 771.53 Unsecured Loan 82.93 591.01 673.94 Loan 11.700 Long Term Unsecured For Dahej Site related activities
9 DIAMINES AND CHEMICALS LIMITED DACL Fine Chem Limited Wholly Owned Subsidiary company Any other transaction Interest receivable (gross) Interest on loan 31.69 30.65 0.00
10 DIAMINES AND CHEMICALS LIMITED KLJ Organics Diamines limited Associates/Joint Venture Loan 6,300.00 Unsecured Loan 0.00 284.41 284.41 Loan 8.00 long Term Unsecured Purchase of Fixed Assets and Expenses
11 DIAMINES AND CHEMICALS LIMITED KLJ Organics Diamines limited Associates/Joint Venture Any other transaction Interest receivable (gross) Interst on loan 11.67 54.67 66.34
12 DIAMINES AND CHEMICALS LIMITED Reaxa Chemistry Solutions LLP Other related Party Purchase of goods or services 75.00 As per the Companies Act, 2013 36.95 0.00 0.00
13 DIAMINES AND CHEMICALS LIMITED S Amit & Co. Other related Party Any other transaction Reimbursement of Exp (Net of Advance) As per the Companies Act, 2013 3.22 0.00 0.11
14 DIAMINES AND CHEMICALS LIMITED DACL Fine Chem Limited Wholly Owned Subsidiary company Sale of goods or services 94.87 As per the Companies Act, 2013 0.00 2.40 0.00
15 DIAMINES AND CHEMICALS LIMITED Mr. Tanmay Godiawala Director Any other transaction Reimbursement of Exp (Net of Advance) As per the Companies Act, 2013 14.58 0.00 0.05
16 DIAMINES AND CHEMICALS LIMITED Mr. Amit M Mehta Executive Chairman Any other transaction Rent Payment As per the Companies Act, 2013 42.00 0.00 0.00 Textual Information(5)
17 DIAMINES AND CHEMICALS LIMITED Mr. Amit M Mehta Executive Chairman Any other transaction Reimbursement from Related Party As per the Companies Act, 2013 0.14 0.00 0.08
18 DIAMINES AND CHEMICALS LIMITED Reaxa Ltd. (UK) Other related Party Sale of goods or services 100.00 As per the Companies Act, 2013 0.00 0.00 0.00
19 DIAMINES AND CHEMICALS LIMITED Reaxa Chemistry Solutions LLP Other related Party Sale of goods or services 12.61 As per agreement 0.00 0.60 0.50 Textual Information(6)
20 DIAMINES AND CHEMICALS LIMITED S Amit Speciality Chemicals Pvt Ltd Other related Party Any other transaction Reimbursement of Exp (Net of Advance) As per the Companies Act, 2013 1.47 0.00 1.25
Total value of transaction during the reporting period 270.42



Text Block

Textual Information(1) Appointment and remuneration of Mr. Amit Mehta is as per the Agreement, approved by the Shareholders
Textual Information(2) Appointment and remuneration of Mr. Tanmay Godiawala is as per the Agreement, approved by the Shareholders
Textual Information(3) Amount includes Preofessional fees Rs. 12 lakhs per year and Sitting Fees Rs.1.72 lakhs, approved by the Shareholders
Textual Information(4) As per Rent Agreement
Textual Information(5) As per the Agreement
Textual Information(6) As per Agreement